Zepp Competitors

Stocks . USA . 
Stock . Zepp Health Corp
ZEPP Stock  USD 16.76  0.74  4.23%   
Zepp Health Corp competes with TTEC Holdings, Expensify, Babcock Wilcox, KULR Technology, and TROOPS; as well as few others. The company conducts business under Electronic Equipment, Instruments & Components sector and is part of Information Technology industry. Analyzing Zepp Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Zepp Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Zepp Health Correlation with its peers.

Zepp Health vs Silvaco Group Correlation

Good diversification

The correlation between Zepp Health Corp and SVCO is -0.12 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Zepp Health Corp and SVCO in the same portfolio, assuming nothing else is changed.

Moving against Zepp Stock

  0.6SOTK Sono Tek CorpPairCorr
  0.55ZDC Zedcor EnergyPairCorr
  0.5ARW Arrow Electronics Earnings Call TomorrowPairCorr
  0.48SYTA Siyata Mobile Symbol ChangePairCorr
  0.46GLW Corning Incorporated Tech BoostPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
11.9918.1624.33
Details
Intrinsic
Valuation
LowRealHigh
15.7529.0435.21
Details
Naive
Forecast
LowNextHigh
9.8416.0122.18
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
15.6923.6331.56
Details

Zepp Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Zepp Health and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Zepp and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Zepp Health Corp does not affect the price movement of the other competitor.

High positive correlations

XTKG
+ 0.77
ARAI
TROO
+ 0.7
BW
STEM
+ 0.57
KULR
KULR
+ 0.55
TTEC
EXFY
+ 0.51
TTEC
ARAI
+ 0.5
EXFY
  

High negative correlations

XTKG
- 0.9
TROO
ARAI
- 0.81
TROO
ARAI
- 0.77
BW
XTKG
- 0.65
BW
BW
- 0.52
EXFY
TROO
- 0.51
EXFY

Risk-Adjusted Indicators

There is a big difference between Zepp Stock performing well and Zepp Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Zepp Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Zepp Health Competitive Analysis

The better you understand Zepp Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Zepp Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Zepp Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ZEPP TTEC EXFY BW KULR TROO STEM ARAI XTKG SVCO
 4.23 
 16.76 
Zepp
 1.28 
 3.16 
TTEC
 4.32 
 1.45 
Expensify
 16.86 
 9.27 
Babcock
 8.33 
 3.08 
KULR
 5.96 
 4.09 
TROOPS
 6.45 
 14.37 
Stem
 1.78 
 1.72 
Arrive
 34.15 
 0.27 
XTKG
 5.56 
 3.91 
Silvaco
Market Volatility
(90 Days Market Risk)
Not too volatile
Relatively risky
Very risky
Relatively risky
Dangerous
Very risky
Somewhat reliable
Dangerous
Out of control
Moderately volatile
Market Performance
(90 Days Performance)
Weakest
Weak
Weakest
Good
Weak
Solid
Weakest
Weakest
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
High
Small
Low
Fair
Low
Small
Risky
High
Risky
Low
Current Valuation
(Equity Enterprise Value)
Under Valued
Under Valued
Under Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Buy
Buy
Buy
Strong Buy
Strong Sell
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Cautious Hold
Hold
Hold
Strong Sell
Hold
Strong Sell
Cautious Hold
Strong Sell
Strong Sell
Current Ratio
1.66
1.61
2.74
1.7
1.12
2.84
2.4
N/A
N/A
N/A
Net Asset
3.86 B
1.75 B
173.68 M
726.99 M
62.93 M
79.19 M
437.36 M
987.79 K
86.4 M
142.34 M
Profit Margin
-0.28
-0.0084
-0.11
-0.15
-1.33
-0.86
0.62
N/A
N/A
-0.48
EBITDA
(345.66 M)
(54.25 M)
5.99 M
2.06 M
(14.36 M)
(11.18 M)
(790.4 M)
(4.5 M)
(12.47 M)
(36.74 M)
Operating Margin
-0.0117
0.028
-0.0644
0.0421
-1.54
-0.16
-0.34
N/A
-1.9
-0.35
Current Valuation
406.32 M
1.07 B
79.38 M
1.56 B
146.52 M
460.21 M
417.98 M
305.19 M
9.32 M
126.96 M
Price To Book
1.14
0.58
0.95
60.56
1.04
5.91
0.63
50.64
0.19
1.73
Retained Earnings
208.88 M
546.62 M
(150.83 M)
(1.65 B)
(83.81 M)
(89.01 M)
(1.63 B)
(15.92 M)
(255.79 M)
(28.01 M)
Current Asset
N/A
415.07 M
N/A
978.18 M
436.42 K
N/A
2.11 M
N/A
N/A
N/A
Five Year Return
N/A
1.36
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Beta
1.39
1.05
1.7
1.53
1.93
2.97
1.27
N/A
1.65
N/A
Number Of Employees
765
52 K
115
1.9 K
52
42
569
33
137
279
Shares Outstanding
7.04 M
48.55 M
80.84 M
111.1 M
45.68 M
122.16 M
8.39 M
33.02 M
16.01 M
30.64 M
Cash Flow From Operations
(24.39 M)
(58.82 M)
23.88 M
(118.73 M)
(17.34 M)
1.96 M
(36.65 M)
(2.29 M)
(992.44 K)
(19.77 M)
Total Debt
1.33 B
1.08 B
6.47 M
537.93 M
1.85 M
26 K
542.02 M
19.08 K
11.39 M
1.69 M
Return On Equity
-0.24
-0.0345
-0.12
-3.47
-0.29
-0.19
-59.21
-2.02
-0.97
-0.34
Return On Asset
-0.0365
0.0305
-0.0469
0.0062
-0.23
-0.0398
-0.0948
N/A
-0.0664
-0.11
Number Of Shares Shorted
396.34 K
5.11 M
2.54 M
2.86 M
8.63 M
827.34 K
979.64 K
312.79 K
169.61 K
1.04 M
Book Value Per Share
14.31
5.44
1.46
-2.09
3.47
0.63
-28.09
0.2
6.86
2.59
Current Liabilities
N/A
206.91 M
N/A
561.35 M
548.49 K
N/A
3.47 M
N/A
N/A
N/A
Total Asset
3.86 B
1.75 B
173.68 M
726.99 M
62.93 M
79.19 M
437.36 M
987.79 K
86.4 M
142.34 M
Debt To Equity
0.62
1.72
0.74
N/A
1.9
0.002
0.9
N/A
N/A
N/A
Short Ratio
1.64
19.53
4.83
0.92
3.42
1.49
4.29
0.14
0.03
5.95
Target Price
64.37
5.0
2.83
8.75
10.0
N/A
19.17
N/A
N/A
9.5
Last Dividend Paid
N/A
0.06
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
33.29
33.38
39.93
73.86
19.58
0.08
25.95
N/A
0.15
22.74
Market Capitalization
362.08 M
153.42 M
129.32 M
1.24 B
153.49 M
488.52 M
130.89 M
346.09 M
9.74 M
136.96 M
Price To Earning
7.11
18.65
71.69
42.82
-77.54
N/A
10.62
N/A
N/A
N/A
Price To Earnings To Growth
-26.7
0.22
-0.97
-0.08
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
1.1
0.0719
0.9
1.72
9.2
32.39
0.79
N/A
1.01
2.19
Net Income
(75.81 M)
(310.62 M)
(10.05 M)
(59.78 M)
(17.52 M)
(13.41 M)
(854.01 M)
(4.54 M)
(83.83 M)
(39.4 M)
Earnings Per Share
-4.0
-0.37
-0.17
-0.7
-0.56
-0.13
-13.39
-0.19
-285.96
-0.92
Shares Owned By Insiders
5.9
58.64
25.09
5.58
6.7
50.25
4.66
91.24
N/A
70.92
Revenue
1.33 B
2.21 B
139.24 M
717.33 M
10.74 M
10.07 M
144.58 M
N/A
11.61 M
59.68 M
Working Capital
56.2 M
298.36 M
98.87 M
101.69 M
29.5 M
13.64 M
7.82 M
(1.34 M)
(8.96 M)
72.79 M
Cash And Equivalents
996.59 M
163.2 M
105.54 M
23.4 M
16.17 M
3.48 M
334.89 M
N/A
N/A
N/A
Cash Per Share
16.22
3.46
1.29
0.81
0.14
0.03
2.17
N/A
N/A
N/A
Gross Profit
86.7 M
496.94 M
73.07 M
188.63 M
1.86 M
(1.1 M)
36.37 M
(120.1 K)
3.77 M
49.6 M
Day Typical Price
16.98
3.17
1.42
10.02
3.14
4.04
14.51
1.71
0.31
3.99
Accumulation Distribution
7538.28
20261.08
57068.69
894465.0
175595.0
61053.94
26837.08
60247.99
2 M
30430.41
Daily Balance Of Power
(0.47)
0.2353
0.6
(0.80)
(0.74)
0.6389
(0.55)
0.1304
(1.08)
(0.53)
Period Momentum Indicator
(0.74)
0.04
0.06
(1.88)
(0.28)
0.23
(0.99)
0.03
(0.14)
(0.23)
Rate Of Daily Change
0.96
1.01
1.04
0.83
0.92
1.06
0.94
1.02
0.66
0.94
Day Median Price
17.09
3.18
1.4
10.4
3.17
4.02
14.59
1.71
0.34
4.03
Price Action Indicator
(0.69)
0.005
0.08
(2.07)
(0.23)
0.18
(0.71)
0.03
(0.13)
(0.23)
Relative Strength Index
34.7
45.51
47.71
58.44
45.32
61.57
40.23
28.58
31.34
39.95
Coefficient Of Variation
(982.55)
(29,540)
(3,720)
442.02
(10,483)
407.65
(3,064)
(319.73)
(2,335)
(1,337)
Mean Deviation
4.25
2.96
2.36
5.37
5.31
5.55
4.03
4.08
13.4
3.07
Jensen Alpha
(0.70)
(0.14)
(0.16)
1.68
(0.28)
1.64
(0.34)
(1.71)
(1.10)
(0.40)
Total Risk Alpha
(1.10)
(0.31)
(0.34)
1.2
(0.59)
1.23
(0.57)
(1.92)
(3.06)
(0.59)
Sortino Ratio
N/A
N/A
N/A
0.2577
N/A
0.2877
N/A
N/A
N/A
N/A
Downside Variance
N/A
N/A
N/A
45.32
N/A
35.6
N/A
N/A
N/A
N/A
Standard Deviation
6.19
3.87
3.24
7.95
6.9
7.26
5.26
4.94
26.11
3.89
Kurtosis
1.5
1.35
2.72
3.5
0.1568
1.34
0.6045
(0.46)
11.05
(0.38)
Potential Upside
8.96
5.23
4.83
13.18
13.83
13.53
7.9
5.35
24.24
5.8
Treynor Ratio
(0.62)
(0.01)
(0.09)
0.92
(0.02)
0.7154
(0.06)
(0.53)
2.15
(0.16)
Maximum Drawdown
31.69
17.83
15.27
44.19
27.63
41.09
27.42
20.7
160.0
15.65
Variance
38.31
14.99
10.51
63.26
47.55
52.74
27.63
24.39
681.76
15.14
Market Risk Adjusted Performance
(0.61)
(0.0009)
(0.08)
0.93
(0.01)
0.7254
(0.05)
(0.52)
2.16
(0.15)
Risk Adjusted Performance
(0.07)
0.0056
(0.01)
0.1755
0.0019
0.1894
(0.02)
(0.22)
(0.02)
(0.05)
Skewness
(0.14)
(0.70)
(0.45)
1.01
0.7277
0.6131
0.3524
(0.30)
1.82
(0.07)
Semi Deviation
N/A
N/A
N/A
5.43
N/A
5.05
N/A
N/A
N/A
N/A
Information Ratio
(0.11)
(0.02)
(0.05)
0.2181
(0.02)
0.2364
(0.04)
(0.33)
(0.05)
(0.09)
Value At Risk
(13.63)
(5.51)
(4.17)
(8.36)
(8.81)
(9.09)
(7.96)
(10.73)
(34.15)
(6.62)
Expected Short fall
N/A
N/A
N/A
(6.12)
N/A
(6.93)
N/A
N/A
N/A
N/A
Downside Deviation
N/A
N/A
N/A
6.73
N/A
5.97
N/A
N/A
N/A
N/A
Semi Variance
N/A
N/A
N/A
29.45
N/A
25.54
N/A
N/A
N/A
N/A

Zepp Health Competition Performance Charts

Five steps to successful analysis of Zepp Health Competition

Zepp Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Zepp Health Corp in relation to its competition. Zepp Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Zepp Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Zepp Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Zepp Health Corp, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Zepp Health position

In addition to having Zepp Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Market Neutral Funds Thematic Idea Now

Market Neutral Funds
Market Neutral Funds Theme
Funds or Etfs that invest in both long and short positions of different entities to enhance returns from broad market movements over time. The Market Neutral Funds theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Market Neutral Funds Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Zepp Stock Analysis

When running Zepp Health's price analysis, check to measure Zepp Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zepp Health is operating at the current time. Most of Zepp Health's value examination focuses on studying past and present price action to predict the probability of Zepp Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zepp Health's price. Additionally, you may evaluate how the addition of Zepp Health to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY